Attenuated suppression of the oxidative burst by cells dying in the presence of oxidized low density lipoprotein

Journal of Lipid Research

Volumn 50, Issue 11, 2009, Pages 2173-2181

  Namgaladze, Dmitry ^a   Jennewein, Carla ^a   Preiss, Stefan ^a   von Knethen, Andreas ^a   Brüne, Bernhard ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Apoptosis; Lipoproteins; Macrophages; NADPH oxidase; Phagocytosis; Reactive oxygen species

Indexed keywords

INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLSERINE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STAUROSPORINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CHEMOKINE CCL2; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; HUMANS; INTERLEUKIN-6; JURKAT CELLS; LIPOPOLYSACCHARIDES; LIPOPROTEINS, LDL; MACROPHAGES; MONOCYTES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHAGOCYTOSIS; PHOSPHATIDYLSERINES; PHOSPHORYLATION; PPAR GAMMA; REACTIVE OXYGEN SPECIES; RESPIRATORY BURST; STAUROSPORINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70350370452     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800615-JLR200     Document Type: Article

References (36)

1. Savill, J., I. Dransfield, C. Gregory, and C. Haslett. 2002. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2: 965-975.
2. Erwig, L. P., and P. M. Henson. 2007. Immunological consequences of apoptotic cell phagocytosis. Am. J. Pathol. 171: 2-8.
3. Johann, A. M., A. von Knethen, D. Lindemann, and B. Brune. 2006. Recognition of apoptotic cells by macrophages activates the peroxisome proliferator-activated receptor-gamma and attenuates the oxidative burst. Cell Death Differ. 13: 1533-1540.
4. Serinkan, B. F., F. Gambelli, A. I. Potapovich, H. Babu, M. Di Giuseppe, L. A. Ortiz, J. P. Fabisiak, and V. E. Kagan. 2005. Apoptotic cells quench reactive oxygen and nitrogen species and modulate TNF-alpha/ TGF-beta1 balance in activated macrophages: involvement of phosphatidylserine-dependent and -independent pathways. Cell Death Differ. 12: 1141-1144.
5. Johann, A. M., V. Barra, A. M. Kuhn, A. Weigert, A. von Knethen, and B. Brune. 2007. Apoptotic cells induce arginase II in macrophages, thereby attenuating NO production. FASEB J. 21: 2704-2712.
6. Fadok, V. A., D. L. Bratton, A. Konowal, P. W. Freed, J. Y. Westcott, and P. M. Henson. 1998. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/ paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101: 890-898.
7. Voll, R. E., M. Herrmann, E. A. Roth, C. Stach, J. R. Kalden, and I. Girkontaite. 1997. Immunosuppressive effects of apoptotic cells. Nature. 390: 350-351.
8. Weigert, A., N. Tzieply, A. von Knethen, A. M. Johann, H. Schmidt, G. Geisslinger, and B. Brune. 2007. Tumor cell apoptosis polarizes macrophages: role of sphingosine-1-phosphate. Mol. Biol. Cell. 18: 3810-3819.
9. Tabas, I. 2005. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler. Thromb. Vasc. Biol. 25: 2255-2264.
10. Shah, P. K. 2007. Molecular mechanisms of plaque instability. Curr. Opin. Lipidol. 18: 492-499.
11. Schrijvers, D. M., G. R. De Meyer, A. G. Herman, and W. Martinet. 2007. Phagocytosis in atherosclerosis: molecular mechanisms and implications for plaque progression and stability. Cardiovasc. Res. 73: 470-480.
12. Sambrano, G. R., and D. Steinberg. 1995. Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine. Proc. Natl. Acad. Sci. USA. 92: 1396-1400.
13. Chang, M. K., C. Bergmark, A. Laurila, S. Horkko, K. H. Han, P. Friedman, E. A. Dennis, and J. L. Witztum. 1999. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc. Natl. Acad. Sci. USA. 96: 6353-6358.
14. Khan, M., S. Pelengaris, M. Cooper, C. Smith, G. Evan, and J. Betteridge. 2003. Oxidised lipoproteins may promote inflammation through the selective delay of engulfment but not binding of apoptotic cells by macrophages. Atherosclerosis. 171: 21-29.
15. Miller, Y. I., S. Viriyakosol, C. J. Binder, J. R. Feramisco, T. N. Kirkland, and J. L. Witztum. 2003. Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J. Biol. Chem. 278: 1561-1568.
16. Greenberg, M. E., M. Sun, R. Zhang, M. Febbraio, R. Silverstein, and S. L. Hazen. 2006. Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J. Exp. Med. 203: 2613-2625.
17. Schrijvers, D. M., G. R. De Meyer, M. M. Kockx, A. G. Herman, and W. Martinet. 2005. Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 25: 1256-1261.
18. Li, Y., M. C. Gerbod-Giannone, H. Seitz, D. Cui, E. Thorp, A. R. Tall, G. K. Matsushima, and I. Tabas. 2006. Cholesterol-induced apoptotic macrophages elicit an inflammatory response in phagocytes, which is partially attenuated by the Mer receptor. J. Biol. Chem. 281: 6707-6717.
19. Namgaladze, D., A. Kollas, and B. Brune. 2008. Oxidized LDL attenuates apoptosis in monocytic cells by activating ERK signaling. J. Lipid Res. 49: 58-65.
20. Schrijvers, D. M., W. Martinet, G. R. De Meyer, L. Andries, A. G. Herman, and M. M. Kockx. 2004. Flow cytometric evaluation of a model for phagocytosis of cells undergoing apoptosis. J. Immunol. Methods. 287: 101-108.
21. Dang, P. M., F. Morel, M. A. Gougerot-Pocidalo, and J. El Benna. 2003. Phosphorylation of the NADPH oxidase component p67(PHOX) by ERK2 and P38MAPK: selectivity of phosphorylated sites and existence of an intramolecular regulatory domain in the tetratricopeptide-rich region. Biochemistry. 42: 4520-4526.
22. Dewas, C., M. Fay, M. A. Gougerot-Pocidalo, and J. El-Benna. 2000. The mitogen-activated protein kinase extracellular signal-regulated kinase 1/ 2 pathway is involved in formyl-methionyl-leucyl-phenylalanine-induced p47phox phosphorylation in human neutrophils. J. Immunol. 165: 5238-5244.
23. Reddy, S. M., K. H. Hsiao, V. E. Abernethy, H. Fan, A. Longacre, W. Lieberthal, J. Rauch, J. S. Koh, and J. S. Levine. 2002. Phagocytosis of apoptotic cells by macrophages induces novel signaling events leading to cytokine-independent survival and inhibition of proliferation: activation of Akt and inhibition of extracellular signal-regulated kinases 1 and 2. J. Immunol. 169: 702-713.
24. Patel, V. A., A. Longacre, K. Hsiao, H. Fan, F. Meng, J. E. Mitchell, J. Rauch, D. S. Ucker, and J. S. Levine. 2006. Apoptotic cells, at all stages of the death process, trigger characteristic signaling events that are divergent from and dominant over those triggered by necrotic cells: Implications for the delayed clearance model of autoimmunity. J. Biol. Chem. 281: 4663-4670.
25. Zhuang, J., Y. Ren, R. T. Snowden, H. Zhu, V. Gogvadze, J. S. Savill, and G. M. Cohen. 1998. Dissociation of phagocyte recognition of cells undergoing apoptosis from other features of the apoptotic program. J. Biol. Chem. 273: 15628-15632.
26. Salvayre, R., N. Auge, H. Benoist, and A. Negre-Salvayre. 2002. Oxidized low-density lipoprotein-induced apoptosis. Biochim. Biophys. Acta. 1585: 213-221.
27. Nhan, T. Q., W. C. Liles, A. Chait, J. T. Fallon, and S. M. Schwartz. 2003. The p17 cleaved form of caspase-3 is present within viable macrophages in vitro and in atherosclerotic plaque. Arterioscler. Thromb. Vasc. Biol. 23: 1276-1282.
28. Boullier, A., Y. Li, O. Quehenberger, W. Palinski, I. Tabas, J. L. Witztum, and Y. I. Miller. 2006. Minimally oxidized LDL offsets the apoptotic effects of extensively oxidized LDL and free cholesterol in macrophages. Arterioscler. Thromb. Vasc. Biol. 26: 1169-1176.
29. Asmis, R., and J. G. Begley. 2003. Oxidized LDL promotes peroxide-mediated mitochondrial dysfunction and cell death in human macrophages: a caspase-3-independent pathway. Circ. Res. 92: e20-e29.
30. Hirt, U. A., and M. Leist. 2003. Rapid, noninflammatory and PS-dependent phagocytic clearance of necrotic cells. Cell Death Differ. 10: 1156-1164.
31. Brouckaert, G., M. Kalai, D. V. Krysko, X. Saelens, D. Vercammen, M. Ndlovu, G. Haegeman, K. D'Herde, and P. Vandenabeele. 2004. Phagocytosis of necrotic cells by macrophages is phosphatidylserine dependent and does not induce inflammatory cytokine production. Mol. Biol. Cell. 15: 1089-1100.
32. Cvetanovic, M., and D. S. Ucker. 2004. Innate immune discrimination of apoptotic cells: repression of proinflammatory macrophage transcription is coupled directly to specific recognition. J. Immunol. 172: 880-889.
33. Fadok, V. A., D. L. Bratton, L. Guthrie, and P. M. Henson. 2001. Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases. J. Immunol. 166: 6847-6854.
34. Scaffidi, P., T. Misteli, and M. E. Bianchi. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 418: 191-195.
35. Sheppard, F. R., M. R. Kelher, E. E. Moore, N. J. McLaughlin, A. Banerjee, and C. C. Silliman. 2005. Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation. J. Leukoc. Biol. 78: 1025-1042.
36. Jennewein, C., A. M. Kuhn, M. V. Schmidt, V. Meilladec-Jullig, A. von Knethen, F. J. Gonzalez, and B. Brune. 2008. Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines. J. Immunol. 181: 5646-5652.